RVMD Revolution Medicines, Inc.
Revolution Medicines, Inc. (RVMD) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $4.3M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Mancini Anthony | See Remarks | Sell 10b5-1 | 3,121 | $200.54 | $625.9K | 39,765 −7.3% of holding | |
| Cislini Jeff | SVP & General Counsel | Sell 10b5-1 | 765 | $207.32 | $158.6K | 51,776 −1.5% of holding | |
| Mancini Anthony | See Remarks | Sell 10b5-1 | 587 | $200.00 | $117.4K | 39,765 −1.5% of holding | |
| ANDERSON ELIZABETH M 5 fills | Director | Sell 10b5-1 | 10,143 | $193.04 | $2.0M | 13,566 −42.8% of holding | |
| Mancini Anthony | See Remarks | Sell 10b5-1 | 1,764 | $196.94 | $347.4K | 40,352 −4.2% of holding | |
| GOLDSMITH MARK A 2 fills | See Remarks | Sell 10b5-1 | 13,988 | $199.24 | $2.8M | 267,117 −5% of holding | |
| Kelsey Stephen Michael 2 fills | See Remarks | Sell 10b5-1 | 5,569 | $199.24 | $1.1M | 291,791 −1.9% of holding | |
| Horn Margaret A 2 fills | Chief Operating Officer | Sell 10b5-1 | 4,967 | $199.24 | $989.6K | 154,571 −3.1% of holding | |
| Anders Jack 2 fills | Chief Financial Officer | Sell 10b5-1 | 4,053 | $199.24 | $807.5K | 123,208 −3.2% of holding | |
| Cislini Jeff 2 fills | SVP & General Counsel | Sell 10b5-1 | 3,366 | $199.24 | $670.6K | 55,855 −5.7% of holding | |
| Mancini Anthony 2 fills | See Remarks | Sell 10b5-1 | 1,774 | $199.24 | $353.4K | 43,863 −3.9% of holding | |
| Sandler Alan B. 2 fills | Chief Development Officer | Sell 10b5-1 | 341 | $199.24 | $67.9K | 53,204 −0.6% of holding | |
| Kelsey Stephen Michael 8 fills | See Remarks | Sell 10b5-1 | 92,531 | $202.36 | $18.7M | 383,607 −19.4% of holding | |
| Mancini Anthony 5 fills | See Remarks | Sell 10b5-1 | 15,448 | $204.16 | $3.2M | 53,319 −22.5% of holding | |
| Kim Lorence H. 7 fills | Director | Sell 10b5-1 | 17,090 | $209.82 | $3.6M | 16,384 −51.1% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.